Platelet Rich Fibrin for Tooth Abscess
(EMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether using platelet-rich fibrin (PRF) during a type of dental surgery can reduce pain and improve healing. PRF, a substance made from blood, may help wounds heal faster. The trial compares outcomes from surgeries performed with and without PRF. It seeks participants who have had unsuccessful root canal treatments and specific issues with their front teeth or premolars. As a Phase 4 trial, this research aims to understand how an already FDA-approved and effective treatment can benefit more patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What is the safety track record for Platelet Rich Fibrin?
Research has shown that Platelet Rich Fibrin (PRF) is generally safe for people. PRF aids in wound healing and reduces side effects after dental procedures. One study found that only 24% of people experienced pain with PRF, compared to 42% without it, suggesting that PRF might lessen post-surgery pain.
Another study found that PRF reduces pain soon after surgery, particularly in the first week. Made from the patient's own blood, PRF has fewer side effects and is easy to prepare. Overall, PRF appears well-tolerated and can aid in healing and pain relief in dental surgeries.12345Why are researchers enthusiastic about this study treatment?
Unlike standard treatments for tooth abscesses, which often involve antibiotics and drainage, Platelet Rich Fibrin (PRF) offers a novel approach by using the body's own healing agents. PRF is derived from a patient's blood and works by releasing growth factors that promote healing and tissue regeneration. Researchers are excited about PRF because it has the potential to enhance recovery after endodontic microsurgery by accelerating healing and reducing the risk of infection, offering a more natural and possibly more effective alternative to conventional treatments.
What evidence suggests that platelet rich fibrin might be an effective treatment for tooth abscess?
Research has shown that Platelet Rich Fibrin (PRF), which participants in this trial may receive, can accelerate wound healing and support tissue growth, particularly in dental surgeries like tooth extractions. Approximately two-thirds of studies have found that PRF significantly reduces post-surgery pain, especially in the initial days. PRF also enhances the healing of gums and other tissues around the tooth. While its effectiveness in root surgery remains under investigation, current evidence from similar dental surgeries appears promising. In this trial, some participants will undergo microsurgery with PRF, while others will have microsurgery without PRF.26789
Who Is on the Research Team?
Mark Schachman, DMD
Principal Investigator
Are You a Good Fit for This Trial?
This trial is for individuals with conditions like tooth abscess, apical periodontitis, or general periodontitis. Specific eligibility criteria are not provided, so it's best to contact the study organizers for detailed requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endodontic microsurgery with or without Platelet-Rich Fibrin (PRF)
Follow-up
Participants are monitored for healing outcomes through follow-up exams, CBCT imaging, and pain response tracking
What Are the Treatments Tested in This Trial?
Interventions
- Platelet Rich Fibrin
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mark Schachman
Lead Sponsor